Carregant...

Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone

Hsp90 inhibitors are being evaluated extensively in patients with advanced cancers. However, the impact of Hsp90 inhibition on signaling pathways in normal tissues and the effect that this may have on the antitumor activity of these molecularly targeted drugs have not been rigorously examined. Breas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yano, Akihiro, Tsutsumi, Shinji, Soga, Shiro, Lee, Min-Jung, Trepel, Jane, Osada, Hiroyuki, Neckers, Len
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2563126/
https://ncbi.nlm.nih.gov/pubmed/18840695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0805354105
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!